Title : An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.

Pub. Date : 2003 Mar 24

PMID : 12644816






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Thalidomide blocks the activity of angiogenic agents including bFGF, VEGF and IL-6. Thalidomide fibroblast growth factor 2 Homo sapiens